KBC Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$168M Sell
354,583
-29,838
-8% -$15M 0.42% 40
2025
Q4
$179M Sell
384,421
-29,487
-7% -$13.7M 0.41% 43
2025
Q3
$176M Sell
413,908
-27,216
-6% -$10.5M 0.42% 41
2025
Q2
$169M Buy
441,124
+95,950
+28% +$34.6M 0.46% 38
2025
Q1
$119M Sell
345,174
-17,918
-5% -$5.76M 0.37% 56
2024
Q4
$109M Sell
363,092
-15,396
-4% -$5.38M 0.3% 59
2024
Q3
$154M Sell
378,488
-63,326
-14% -$23.2M 0.46% 37
2024
Q2
$142M Buy
441,814
+253,066
+134% +$82.2M 0.43% 38
2024
Q1
$63M Sell
188,748
-177,236
-48% -$54.2M 0.2% 112
2023
Q4
$99.1M Buy
365,984
+926
+0.3% +$229K 0.35% 63
2023
Q3
$89.8M Buy
365,058
+136,597
+60% +$37.4M 0.37% 61
2023
Q2
$69.3M Sell
228,461
-30,286
-12% -$8.42M 0.29% 75
2023
Q1
$68.2M Sell
258,747
-4,520
-2% -$1.15M 0.29% 74
2022
Q4
$63.2M Sell
263,267
-52,794
-17% -$11.8M 0.31% 74
2022
Q3
$58.1M Sell
316,061
-53,242
-14% -$10.6M 0.3% 74
2022
Q2
$62.1M Sell
369,303
-4,503
-1% -$967K 0.31% 81
2022
Q1
$93.7M Sell
373,806
-234,346
-39% -$58.8M 0.37% 71
2021
Q4
$156M Buy
608,152
+199,401
+49% +$48.8M 0.52% 48
2021
Q3
$99.2M Sell
408,751
-190,615
-32% -$46.6M 0.36% 67
2021
Q2
$124M Sell
599,366
-158,978
-21% -$32.4M 0.22% 109
2021
Q1
$143M Buy
758,344
+93,480
+14% +$16.5M 0.29% 79
2020
Q4
$601M Buy
664,864
+206,328
+45% +$30.2M 0.26% 94
2020
Q3
$57.2M Sell
458,536
-134,910
-23% -$16.7M 0.17% 137
2020
Q2
$57.6M Buy
593,446
+240,582
+68% +$25M 0.19% 118
2020
Q1
$31.7M Buy
352,864
+148,589
+73% +$19.2M 0.27% 88
2019
Q4
$30.2M Sell
204,275
-38,534
-16% -$5.17M 0.19% 126
2019
Q3
$29.2M Sell
242,809
-20,573
-8% -$2.66M 0.21% 103
2019
Q2
$35.6M Sell
263,382
-15,263
-5% -$1.93M 0.28% 83
2019
Q1
$36.3M Sell
278,645
-23,798
-8% -$3.2M 0.3% 75
2018
Q4
$37.6M Buy
302,443
+27,276
+10% +$3.66M 0.42% 57
2018
Q3
$38.3M Buy
275,167
+58,954
+27% +$7.34M 0.29% 86
2018
Q2
$22.2M Buy
216,213
+116,446
+117% +$11.8M 0.19% 145
2018
Q1
$9.68M Sell
99,767
-139,980
-58% -$13.6M 0.09% 264
2017
Q4
$21.1M Sell
239,747
-19,520
-8% -$1.57M 0.18% 147
2017
Q3
$20.6M Buy
259,267
+4,732
+2% +$381K 0.19% 135
2017
Q2
$22.2M Sell
254,535
-25,738
-9% -$2.18M 0.21% 126
2017
Q1
$24.9M Buy
280,273
+149,898
+115% +$12.5M 0.23% 109
2016
Q4
$9.65M Sell
130,375
-169,011
-56% -$12.7M 0.1% 257
2016
Q3
$22.6M Buy
299,386
+51,397
+21% +$3.94M 0.27% 85
2016
Q2
$19.1M Buy
247,989
+11,074
+5% +$874K 0.27% 83
2016
Q1
$18.5M Buy
236,915
+12,170
+5% +$850K 0.31% 72
2015
Q4
$15.2M Sell
224,745
-21,720
-9% -$1.52M 0.28% 92
2015
Q3
$19.1M Sell
246,465
-94,666
-28% -$8.38M 0.38% 64
2015
Q2
$30.9M Buy
341,131
+69,421
+26% +$5.56M 0.4% 57
2015
Q1
$20.4M Sell
271,710
-91,450
-25% -$6.57M 0.26% 104
2014
Q4
$26.7M Buy
363,160
+154,320
+74% +$10.8M 0.32% 71
2014
Q3
$14.7M Sell
208,840
-101,564
-33% -$6.71M 0.51% 24
2014
Q2
$17.5M Buy
310,404
+107,546
+53% +$5.67M 0.2% 118
2014
Q1
$10.7M Sell
202,858
-20,600
-9% -$1.03M 0.17% 158
2013
Q4
$10.7M Buy
223,458
+1,732
+0.8% +$80K 0.16% 162
2013
Q3
$9.48M Buy
221,726
+77,336
+54% +$3.02M 0.15% 185
2013
Q2
$5.21M Buy
+144,390
New +$5.59M 0.1% 269

Other funds holding HCA

KBC Group's HCA Position: Q1 2026 in Review

KBC Group reduced its HCA Healthcare (HCA) stake by 7.8% in Q1 2026, selling an estimated $15M and leaving 354,583 shares worth $168M. The position accounts for 0.42% of the portfolio, ranked #40.

KBC Group first reported a position in HCA in Q2 2013 and has held it in 52 quarters since. The position peaked at $601M in Q4 2020. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • KBC Group held 354,583 shares of HCA Healthcare worth $168M as of Q1 2026.
  • KBC Group sold 29,838 HCA Healthcare shares in Q1 2026, an estimated $15M.
  • HCA Healthcare made up 0.42% of KBC Group's portfolio in Q1 2026, its #40 holding.
  • KBC Group first reported a position in HCA Healthcare in Q2 2013 and has held it in 52 quarters since.
  • KBC Group's HCA Healthcare position peaked at $601M in Q4 2020.
  • 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.